1. Home
  2. MURA vs STRM Comparison

MURA vs STRM Comparison

Compare MURA & STRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • STRM
  • Stock Information
  • Founded
  • MURA 2013
  • STRM 1989
  • Country
  • MURA Ireland
  • STRM United States
  • Employees
  • MURA N/A
  • STRM N/A
  • Industry
  • MURA
  • STRM EDP Services
  • Sector
  • MURA
  • STRM Technology
  • Exchange
  • MURA Nasdaq
  • STRM Nasdaq
  • Market Cap
  • MURA 17.7M
  • STRM 15.4M
  • IPO Year
  • MURA N/A
  • STRM 1996
  • Fundamental
  • Price
  • MURA $2.63
  • STRM $2.59
  • Analyst Decision
  • MURA Strong Buy
  • STRM
  • Analyst Count
  • MURA 4
  • STRM 0
  • Target Price
  • MURA $13.00
  • STRM N/A
  • AVG Volume (30 Days)
  • MURA 14.0M
  • STRM 5.9K
  • Earning Date
  • MURA 05-20-2025
  • STRM 06-10-2025
  • Dividend Yield
  • MURA N/A
  • STRM N/A
  • EPS Growth
  • MURA N/A
  • STRM N/A
  • EPS
  • MURA N/A
  • STRM N/A
  • Revenue
  • MURA N/A
  • STRM $17,901,000.00
  • Revenue This Year
  • MURA $34.35
  • STRM $18.64
  • Revenue Next Year
  • MURA N/A
  • STRM N/A
  • P/E Ratio
  • MURA N/A
  • STRM N/A
  • Revenue Growth
  • MURA N/A
  • STRM N/A
  • 52 Week Low
  • MURA $0.95
  • STRM $1.82
  • 52 Week High
  • MURA $4.74
  • STRM $9.75
  • Technical
  • Relative Strength Index (RSI)
  • MURA 56.94
  • STRM 44.37
  • Support Level
  • MURA $2.48
  • STRM $2.30
  • Resistance Level
  • MURA $2.66
  • STRM $3.40
  • Average True Range (ATR)
  • MURA 0.12
  • STRM 0.27
  • MACD
  • MURA 0.04
  • STRM 0.01
  • Stochastic Oscillator
  • MURA 42.58
  • STRM 32.32

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About STRM Streamline Health Solutions Inc.

Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.

Share on Social Networks: